Commentary: Time to convert? Minimally invasive surgery following induction immunotherapy Editorial

  

Authors:	Gray, K. D.; Bott, M. J.
Title:	Commentary: Time to convert? Minimally invasive surgery following induction immunotherapy
Keywords:	treatment response; cancer surgery; cancer growth; cancer immunotherapy; morbidity; editorial; length of stay; minimal residual disease; drug response; operation duration; minimally invasive surgery; neoadjuvant chemotherapy; cancer control; non small cell lung cancer; phase 2 clinical trial (topic); human; pembrolizumab
Journal Title:	Journal of Thoracic and Cardiovascular Surgery
Volume:	163
Issue:	2
ISSN:	0022-5223
Publisher:	Mosby Elsevier
Date Published:	2022-02-01
Start Page:	437
End Page:	438
Language:	English
DOI:	10.1016/j.jtcvs.2021.03.086
PUBMED:	33941374
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85105042131&doi=10.1016%2fj.jtcvs.2021.03.086&partnerID=40&md5=019c790cc225b9f5eb4da1bdae005a33
Notes:	Editorial -- Export Date: 1 February 2022 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/192335